drugset / Trial / NCT01613053
Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination
Summary
Continuation of drug supply in Chinese patients after CAMN107DBR01study termination.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imatinib | Small molecule | 800 mg | — |